Logo image of PROF

PROFOUND MEDICAL CORP (PROF) Stock Earnings & Estimates

NASDAQ:PROF - CA74319B5027 - Common Stock

4.12 USD
-0.3 (-6.79%)
Last: 9/5/2025, 8:00:01 PM
4.17 USD
+0.05 (+1.21%)
After Hours: 9/5/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
PROF revenue by date.PROF revenue by date.
6.681M
-2.79%
7.199M
7.75%
10.68M
48.35%
17.096M
60.07%
37.919M
121.80%
58.621M
54.60%
125.24M
113.64%
181.99M
45.31%
254.09M
39.62%
322.58M
26.96%
399.95M
23.98%
EBITDA
YoY % growth
PROF ebitda by date.PROF ebitda by date.
-27.998M
1.46%
-27.47M
1.89%
-32.126M
-16.95%
-38.555M
-20.01%
-28.482M
26.13%
-10.676M
62.52%
29.212M
373.63%
60.056M
105.59%
105.45M
75.59%
138.71M
31.54%
175.98M
26.87%
EBIT
YoY % growth
PROF ebit by date.PROF ebit by date.
-29.602M
2.27%
-28.616M
3.33%
-33.062M
-15.54%
-44.777M
-35.43%
-39.794M
11.13%
-53.732M
-35.03%
40.747M
175.83%
9.432M
-76.85%
32.464M
244.19%
N/AN/A
Operating Margin
PROF operating margin by date.PROF operating margin by date.
-443.08%-397.50%-309.57%-261.91%-104.94%-91.66%32.54%5.18%12.78%N/AN/A
EPS
YoY % growth
PROF eps by date.PROF eps by date.
-1.38
8.00%
-1.35
2.17%
-1.12
17.04%
-1.50
-34.14%
-1.27
15.46%
-1.02
19.68%
0.63
161.35%
1.36
117.77%
2.44
79.24%
3.23
32.21%
4.12
27.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.40
-5.65%
-0.36
-80.54%
-0.39
-9.42%
-0.33
35.90%
-0.29
28.72%
-0.24
33.80%
-0.20
48.72%
-0.12
63.64%
-0.06
78.82%
0.00
100.00%
Revenue
Q2Q % growth
4.767M
68.33%
7.397M
77.09%
7.327M
179.55%
8.553M
286.84%
10.136M
112.63%
12.221M
65.22%
12.387M
69.06%
14.738M
72.31%
17.357M
71.24%
20.241M
65.62%
EBITDA
Q2Q % growth
-10.855M
-30.78%
-9.509M
-28.35%
-11.076M
-0.66%
-9.469M
29.87%
-8.041M
25.92%
-7.479M
21.35%
-5.942M
46.35%
-3.502M
63.02%
-1.633M
79.69%
400.97K
105.36%
EBIT
Q2Q % growth
-11.884M
-32.08%
-10.201M
-22.24%
-12.07M
-8.09%
-11.06M
19.89%
-9.393M
20.96%
-7.676M
24.75%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.52
-85.71%
-0.37-0.15-40.10%
Q1 2025
Q2Q % growth
-0.36
-38.46%
-0.28-0.08-27.30%
Q4 2024
Q2Q % growth
-0.20
52.38%
-0.350.1542.88%
Q3 2024
Q2Q % growth
-0.38
-46.15%
-0.30-0.08-28.63%
Q2 2024
Q2Q % growth
-0.28
20.00%
-0.290.015.06%
Q1 2024
Q2Q % growth
-0.26
18.75%
-0.280.026.39%
Q4 2023
Q2Q % growth
-0.42
8.70%
-0.32-0.10-30.15%
Q3 2023
Q2Q % growth
-0.26
-8.33%
-0.340.0823.48%
Q2 2023
Q2Q % growth
-0.35
-25.00%
-0.360.012.34%
Q1 2023
Q2Q % growth
-0.32
20.00%
-0.360.0411.99%
Q4 2022
Q2Q % growth
-0.46
6.12%
-0.37-0.09-23.09%
Q3 2022
Q2Q % growth
-0.24
17.24%
-0.370.1335.19%
Q2 2022
Q2Q % growth
-0.28
20.00%
-0.400.1229.52%
Q1 2022
Q2Q % growth
-0.40
-8.11%
-0.460.0613.90%
Q4 2021
Q2Q % growth
-0.49
-28.94%
-0.34-0.15-45.55%
Q3 2021
Q2Q % growth
-0.29
10.17%
-0.27-0.02-8.35%
Q2 2021
Q2Q % growth
-0.35
-5.43%
-0.29-0.06-20.88%
Q1 2021
Q2Q % growth
-0.37
-98.84%
-0.27-0.10-39.15%
Q4 2020
Q2Q % growth
-0.38
-11.44%
-0.31-0.07-24.05%
Q3 2020
Q2Q % growth
-0.32
25.23%
-0.25-0.08-31.30%
Q2 2020
Q2Q % growth
-0.33
11.19%
-0.22-0.11-48.16%
Q1 2020
Q2Q % growth
-0.19
17.54%
-0.260.0829.29%
Q4 2019
Q2Q % growth
-0.34 -0.490.1531.00%
Q3 2019
Q2Q % growth
-0.43 -0.39-0.04-11.34%
Q2 2019
Q2Q % growth
-0.37 -0.34-0.03-10.00%
Q1 2019
Q2Q % growth
-0.23 -0.340.1133.60%
PROF Yearly EPS VS EstimatesPROF Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
2.211M
-0.99%
3.568M-1.357M-38.03%
Q1 2025
Q2Q % growth
2.621M
37.23%
3.535M-914K-25.86%
Q4 2024
Q2Q % growth
4.177M
107.91%
4.309M-132K-3.06%
Q3 2024
Q2Q % growth
2.832M
63.89%
2.91M-78K-2.68%
Q2 2024
Q2Q % growth
2.233M
39.39%
2.417M-184K-7.61%
Q1 2024
Q2Q % growth
1.91M
2.69%
2.82M-910K-32.27%
Q4 2023
Q2Q % growth
2.009M
59.82%
1.997M12K0.60%
Q3 2023
Q2Q % growth
1.728M
-15.09%
2.087M-359K-17.20%
Q2 2023
Q2Q % growth
1.602M
-20.89%
2.158M-556K-25.76%
Q1 2023
Q2Q % growth
1.86M
36.36%
2.238M-378K-16.89%
Q4 2022
Q2Q % growth
1.257M
25.95%
2.962M-1.705M-57.56%
Q3 2022
Q2Q % growth
2.035M
-19.79%
2.224M-189K-8.50%
Q2 2022
Q2Q % growth
2.025M
-22.92%
1.818M207K11.39%
Q1 2022
Q2Q % growth
1.364M
91.84%
2.19M-826K-37.72%
Q4 2021
Q2Q % growth
998K
-65.34%
2.592M-1.594M-61.50%
Q3 2021
Q2Q % growth
2.537M
13.36%
3.886M-1.349M-34.71%
Q2 2021
Q2Q % growth
2.627M
156.04%
2.236M391K17.49%
Q1 2021
Q2Q % growth
711K
-38.71%
2.612M-1.901M-72.78%
Q4 2020
Q2Q % growth
2.879M
35.98%
2.271M608.4K26.79%
Q3 2020
Q2Q % growth
2.238M
333.05%
1.837M401K21.83%
Q2 2020
Q2Q % growth
1.026M
138.99%
749.309K276.691K36.93%
Q1 2020
Q2Q % growth
1.16M
4.47%
882.023K277.977K31.52%
Q4 2019
Q2Q % growth
2.118M 2.073M44.5K2.15%
Q3 2019
Q2Q % growth
516.8K 1.179M-662.2K-56.17%
Q2 2019
Q2Q % growth
429.3K 983.316K-554.016K-56.34%
Q1 2019
Q2Q % growth
1.11M 780.972K329.428K42.18%
PROF Yearly Revenue VS EstimatesPROF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.43% -89.29% -34.01% -34.01%
Revenue-1.16% -50.32% -2.39% -6.48%